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PURPOSE. The cone-rod homeobox (CRX) transcription factor is essential for photoreceptor
gene expression, differentiation, and survival. Human CRX mutations can cause dominant
retinopathies of varying onset and phenotype severity. In animal models, dominant frameshift
Crx mutations introduce a premature termination codon (PTC), producing inactive truncated
proteins that interfere with normal CRX function. Previously, a mutant mouse, TVRM65, was
reported to carry a recessive late PTC mutation, Crx-L253X. More detailed phenotype analysis
of the pathogenicity of Crx-L253X sheds new light on the variability of CRX-linked diseases.
METHODS. Homozygous (L253X/X); heterozygous (L253X/þ); Crx/ and control C57BL/6J
(WT) mice were analyzed at various ages for changes in retinal function (ERG), morphology
(histology) and photoreceptor gene expression (qRT-PCR).
RESULTS. At 1 month, L253X/X mice lack visual function, show greater reductions in retinal
thickness, and distinct gene expression changes relative to Crx/, suggesting that the
phenotype of L253X/X is more severe than Crx/. L253X/þ mice have reduced rod/cone
function, but normal retinal morphology at all ages tested. qRT-PCR assays described a
complex phenotype in which both developing and mature photoreceptors are unable to
maintain proper gene expression. L253X mRNA/protein is overexpressed relative to normal
Crx, suggesting a pathogenic mechanism similar to early PTC mutations. However, the
overexpression is less pronounced, correlating with a relatively mild dominant phenotype.
CONCLUSIONS. The L253X mouse provides a valuable model for CRX-associated retinopathy.
The pathogenicity of CRX frameshift mutations depends on the position of the PTC, which in
turn determines the degree of mutant mRNA/protein overproduction.
Keywords: CRX mutations, animal models, inherited photoreceptor degeneration, cone-rod
dystrophy, gene expression
The cone-rod homeobox protein (CRX) is a transcriptionfactor (TF) that regulates expression of many photorecep-
tor genes essential for the development and maintenance of
both rod and cone photoreceptors.1–4 Human CRX mutations
are associated with various diseases, including retinitis pigmen-
tosa (RP); cone-rod dystrophy (CoRD); and Leber congenital
amaurosis (LCA).5,6 CRX-linked diseases are largely inherited in
an autosomal dominant fashion or arise de novo, and vary
widely in severity and age of onset.5,7–10 Since CRX mutations
can be detected with early genetic testing, we need to be able
to predict their effects and to define effective treatment and
gene therapy regimens.7
Previous research has divided disease causing CRX mutations
into four classes.11 Classes I and II are missense mutations that
fall within or near the region coding for the DNA-binding
homeodomain; class I mutations reduce the binding of CRX to its
DNA targets.12 Previous work has shown by a variety of metrics
that heterozygous mice carrying the class I R90W mutation
suffer from a mild form of CoRD, similar to human patients with
such mutations, while homozygotes exhibit an LCA-like condi-
tion.13 Class III and IV mutations represent frameshift mutations
caused by insertions or deletions in the region coding for the
transactivation domains of CRX.12 Class IV mutations, modeled
by the RIP mouse, cause translation of a much longer peptide
sequence due to a frameshift and extension of the open reading
frame (ORF) into the 30 untranslated region (30UTR).14 In
contrast to this extended peptide sequence, Class III mutations
truncate the ORF of CRX with a premature termination codon
(PTC) that results in a CRX protein with a shortened trans-
activation domain and leads to a severe dominant degenerative
phenotype (LCA or CoRD).13 This phenotype has been modeled
by the E168d2 mouse13 and Rdy (A182d1) cat15 (Fig. 1A). In
vitro DNA binding and transactivation experiments determined
that the E168d2 protein has a similar affinity for CRX target DNA
sequences as normal CRX, but is unable to activate transcription
on its own or in combination with other retinal TFs that
normally synergize with CRX.12,13 Furthermore, when tested
together with normal CRX, E168d2 protein interfered with
normal CRX transactivation in a dominant-negative manner.13
Class III PTC-causing CRX mutations also result in a novel
untranslated region between the PTC and normal stop codon,
which becomes a part of the mutant mRNA transcript’s 30UTR
(Fig. 1A).11 In the E168d2 mouse and the Rdy (A182d1) cat,
longitudinal studies showed gradual accumulation of mutant
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protein and mRNA.13,15 The mechanism for this accumulation
is unknown, but was postulated to arise from decreased
mutant RNA degradation,13 possibly due to the presence of
cryptic stabilizing elements within the PTC-expanded mutant
30UTR. Therefore, the position of the PTC (relative to the
normal termination codon) could determine the stability, and
thus abundance of mutant RNA.
Previously, another PTC mutant mouse, TVRM65 (Crx-
L253X), was discovered in a chemical-induced mutagenesis
screen conducted by The Jackson Laboratory16 (Bar Harbor,
ME, USA; see Methods section for nomenclature specifics). The
L253X mutation (Fig. 1A) occurs later (closer to the normal
termination codon) than E168d2 and A182d1. L253X would
be a candidate to model human late PTC class III mutations,
such as L237I117 and Q256X18 associated with dominant
CoRD. However, the initial histologic assessments suggested
that the L253X mouse phenocopies the recessive null (Crx/)
condition.16 Here, we describe more detailed phenotypic
analysis of L253X mice, which demonstrates that this mouse
models a new dominant but mild form of class III disease. Our
results support the hypothesis that class III mutation pathoge-
nicity depends on the position of the mutation-induced PTC (a
late PTC produces a less severe phenotype than an early PTC),
which correlates with the abundance of mutant protein
products. These findings have implications for predicting
human CRX disease severity and progression.
METHODS
Nomenclature for the TVRM65 Mutation
There are several annotated transcripts for the murine Crx
locus. The previously published amino acid change in the
TVRM65 mouse was based on isoform 2 (NM001113330.1)
that encodes a CRX protein with 323 amino acids.16,19
However, the major transcript in the retina is isoform 1
(NM_007770.4), which encodes a CRX protein homologous to
human CRX, with 299 amino acids. Thus, here we refer to the
TVRM65 mutation as p.L253X, based on isoform 1 numbering.
Mice
Crx-L253X (TVRM65) mice16 were obtained from The Jackson
Laboratory (MGI ID: 4867395). Mice were mated and
maintained with C57BL/6J (JAX Stock number 000664), and
FIGURE 1. Class III Crx mutations introduce a PTC, resulting in accumulation of truncated CRX proteins and mutant mRNA with variable extended
30UTR. (A) Schematic representation of normal and mutant Crx mRNA species, showing untranslated (UTR, gray/black lines) and protein-coding
(open/striped boxes) with their relative sizes (bp), based on mouse (Normal, E168d213 and L253X) and cat (A182d1)15 models. The DNA-binding
homeodomain (HD, dark strips) and the activation domain (AD, light strips) sequences12 are indicated. All three mutant mRNAs encode the
complete HD, but ADs are truncated at different positions due to their PTC (indicated as the right-hand end of the protein coding box) induced by
the mutation (marked by an asterisk). These PTCs also expand the 30UTR to include different lengths of the original coding region (indicated by
black line) in front of the normal 30UTR (gray line). The position of the PTC relative to the normal stop codon determines the length of expanded
30UTR: Early PTC mutants, E168d2 and A182d1 (Rdy cat mutation) produce a longer 30UTR than the late PTC mutant L253X. Since 50UTR and
30UTR sequences of feline Crx mRNA are not available, these regions of the A182d1 transcript are indicated by dotted lines. (B) Immunoblot of CRX
in the retinas of WT, L253X/þ, and L253X/X mutants at 1-month old (mo) with GAPDH as a protein loading control. Black arrows indicate the
running position for the normal and mutant (truncated) forms of CRX. (C) Quantification of relative amounts of normal and mutant CRX proteins in
the indicated retinas at three ages (mean 6 SEM, n ‡ 3; * P < 0.05, ** P < 0.01; 2-Way ANOVA with Tukey’s multiple comparisons test). (D) ddPCR
quantification of mutant (L253X) and normal Crx mRNA as percentage of total Crx. The specificity of the two allele-specific ddPCR assays was
established using triplicate tail DNA samples (gray circles) from the indicated genotypes (DNA control). L253X/þmRNA results are presented as
percent of total Crx mRNA (mutant plus normal transcripts; mean 6 SEM, n ‡ 3; **** P < 0.0001; unpaired t-test for mutant mRNA level relative to
L253X/þ DNA control; n ‡ 3).
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confirmed free of rd1 and rd8 mutations by PCR genotyping.
Crx null mice (Crx/) were provided by Constance Cepko,
Harvard University (Boston, MA, USA)20 and back-crossed onto
C57BL/6J for more than 10 generations. All mice were housed
in a barrier facility in the Division of Comparative Medicine of
Washington University School of Medicine. All procedures
involving the use of mice were approved by Washington
University’s Animal Care and Use Committee and followed the
ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research.
PCR genotyping, RNA purification and reverse transcrip-
tion, and qRT-PCR were performed as previously described.13
Primer sets for genotyping and RT-PCR are listed in Supple-
mentary Table S1. For qRT-PCR, all primers were tested for
proper amplification efficiency prior to use. Relative gene
expression was normalized to the retinal constitutively
expressed genes Ubb, Tuba1B, and Gapdh. Data for 3 biologic
replicates were then analyzed using the Delta Cq method in
qPCR analysis software (QBase; Biogazelle, Ghent, Belgium).
The results are presented by the heatmap.2 function of the R
gplots package (v3.0.1).
Droplet Digital PCR (ddPCR)
Confirmatory genotyping and allelic expression data were
generated using the droplet digital PCR system (BioRad,
Hercules, CA, USA). A 20 lL ddPCR reaction mixture
containing custom-designed normal and mutant primer/probe
sets (see Supplementary Table S2) was prepared according to
manufacturer’s directions, droplets generated, and nanoreac-
tions cycled on a thermal cycler (C1000 Touch; Bio-Rad
Laboratories). The average number of allelic transcripts per
biological replicate (n¼3) was then determined with a droplet
reader and analytical software (QX 200 with QuantaSoft
Analysis Pro; Bio-Rad Laboratories).
Transient Transfection Luciferase Reporter Assays
HEK293T cells (ATCC CRL-11286) were cultured in Dulbecco’s
modified Eagle medium with 10% fetal bovine serum and
penicillin/streptomycin. Cells were transfected using a con-
ventional CaCl and boric acid buffered saline method in 6-well
plates as previously described.12,13 Experimental plasmids and
transfection amounts included 2 lg BR130-Luc (a Rho
promoter-luciferase reporter)12; 1 ng pRL-CMV (transfection
normalization control); and protein expression vectors pED-
NRL (100 ng), pcDNA3.1-hCRX, CRX1-254, and CRX-E168d2.
Cells were harvested 48 hours posttransfection and assays
performed using the dual-luciferase reporter assay system
(Promega Corp., Madison, WI, USA).
ERG and Statistical Analyses
These were performed as previously described.13 Briefly, tests
were performed on a visual electrodiagnostic system (UTAS-
E3000 with EM for Windows; LKC Technologies, Inc., Gaithers-
burg, MD, USA) while mouse body temperature was maintained
at 378C 6 0.58C with a heating pad controlled by a rectal
temperature probe (FHC, Inc., Bowdoin, ME, USA). Pupils were
dilated with 1.0% atropine sulfate (Bausch & Lomb, Tampa, FL,
USA) and dilation and corneal hydration maintained during
testing by positioning the platinum wire loop recording
electrodes in a mixture of atropine and 1.25% hydroxypropyl
methylcellulose (GONAK; Akorn, Inc., Buffalo Grove, IL, USA).
Mice were tested without knowledge of genotype. Bilateral flash
ERG responses were obtained; the set of recordings giving the
higher amplitudes was correlated with genotype information for
statistical analyses including 2-way ANOVA and post-hoc
multiple comparison tests were performed using graphing
software (GraphPad Prism; GraphPad Software, Inc., La Jolla,
CA, USA).
Quantitative Western Blot Analysis
As previously described,13 experiments were performed using
three biologic replicates (15 lg total protein extract from
homogenates of two retinas). Membranes were probed with
mouse monoclonal anti-CRX antibody M02 (1:200; Abnova
Corp., Taipei City, Taiwan) and anti-GAPDH antibody
(1:10,000, G9545; Sigma-Aldrich Corp., St. Louis, MO, USA),
visualized with donkey anti-rabbit 680 nm and donkey anti-
mouse 800 nm fluorescent dye (1:10,000 IRDyes; LI-COR, Inc.,
Lincoln, NE, USA), then imaged and quantified using commer-
cial software (Odyssey Infrared Imager and ImageStudio 6; LI-
COR, Inc.).
Histology, Morphometry, Immunohistochemistry,
And Statistical Analyses
These assays were performed as previously described.13
Sagittal sections (4-lm) of paraffin-embedded eyecups, cut
through the optic nerve head, were either stained with
hematoxylin and eosin (H&E) or prepared for immunofluores-
cence staining. Slides containing sections were incubated
overnight with primary antibody at 48C (1:400 anti-Rhodopsin
monoclonal RetP1; Sigma-Aldrich Corp.), washed, and incu-
bated with secondary antibody (1:500 AlexaFluor 568 goat-anti-
mouse; Invitrogen Corp., Carlsbad, CA, USA) for 2 hours at
room temperature. Coverslips were mounted with mounting
medium with DAPI (Vectashield Hardset; Vector Laboratories,
Inc., Burlingame, CA, USA). All imaging was performed using a
microscope and camera (DM5500B and DFC365FX; Leica
Microsystems GmbH, Buffalo Grove, IL, USA).
RESULTS
L253X Overproduces Mutant mRNA/Protein in
Affected Retinas
A hallmark of class III CRX frameshift mutations is the
overexpression of the mutant allele.13,15 To determine if
L253X retinas accumulate mutant protein, we performed
quantitative Western blots on total protein extracts from
retinas of WT and heterozygous L253X/þmice at postnatal day
10 (P10), 1 and 2 months old, and homozygous L253X/X mice
at P10 only (because photoreceptors degenerate before later
ages).16 Immunoblotting with an anti-CRX antibody revealed a
truncated L253X protein that ran faster than the normal full-
length CRX protein in samples from both heterozygous and
homozygous mutant retinas (Fig. 1B). We quantified the total
amount of CRX protein and of each isoform. Both L253X/þ
and L235X/X displayed a 1.5- to 2.2-fold increase in total CRX
protein compared to the WT retinas (Fig. 1C). The increases
can be attributed to an accumulation of mutant protein (black
bar), since normal CRX protein levels (gray bar) in L253X/þ
retinas with one normal allele were roughly half of the total
CRX protein present in WT retinas with two alleles.
To determine if the increased mutant protein corresponded
with an increase in mutant mRNA, we quantified the relative
allelic expression of L253X and normal Crx mRNA using
droplet digital PCR (ddPCR). First, using mutant and WT mouse
DNA, we developed a ddPCR assay that clearly distinguished
the L253X and normal Crx sequences (Fig. 1D, DNA control).
This assay was then used to quantify allele-specific mRNA
species. At all ages tested, the mutant transcript was
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overrepresented, accounting for 57% of total Crx mRNA (Fig.
1D). Total Crx transcript levels quantified by conventional qRT-
PCR (Supplementary Fig. S1) showed a statistically significant
total Crx mRNA increase in 1-month L253X/þ retinas relative
to WT, although levels were comparable to WT retinas during
development at P10 and by 3 months.
Overall, L253X/þ retinas develop and maintain an elevated
level of mutant mRNA that translates into an imbalance of the
two protein forms, but this misregulation is not as severe as
observed in other class III mutants. These results identify Crx-
L253X as a bona fide class III mutation, but suggest that the
position of the PTC determines the toxicity of the allele.
L253X/X Mice Have No Detectable Rod and Cone
Function
Homozygous animals carrying class III or null Crx mutations
lack measurable photoreceptor function.13,15,20 To confirm
that L253X/X photoreceptors are functionally compromised,
we quantified rod/cone light responses in L253X/X and WT
control mice at 1 month using ERG. Even at the highest light
intensity stimuli, L253X/X retinas displayed very little
FIGURE 2. L253X/X retinas lack rod and cone responses to light and degenerate earlier than Crx/. ERG was used to measure rod (dark-adapted)
and cone (light-adapted) responses to various light stimuli in 1-mo L253X/X and WT mice. (A, B) Comparison of representative ERG traces at the
highest light intensity: 0.89 log scot cd/m2 for dark-adapted responses, and 2.67 log scot cd/m2 for light-adapted responses. (C) Bar graphs compare
mean A-wave and/or B-wave amplitude differences between the two genotypes at the highest light intensity tested (mean 6 SEM, n ‡ 3; * P  0.05,
*** P  0.0005, **** P < 0.0001; 2-way ANOVA with Sidak’s multiple comparisons test). (D–F, H–J) H&E-stained paraffin-embedded sagittal retinal
sections from the indicated mice at 1 and 3 mo. Images were taken approximately 500 lm from the ONH at a340 magnification (scale bar: 25 lm).
(G, K) Morphometry measures at five set distances (in microns) on either side of the ONH (mean 6 SEM, n ‡ 3; * P  0.05, ** P < 0.01, *** P 
0.0003; 2-way ANOVA with Sidak’s multiple comparisons test).
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response (Figs. 2A–C). These results confirm that, like other
class III models, homozygous L253X/X animals lack photore-
ceptor visual responses, resembling human LCA.
L253X/X Photoreceptors Degenerate Earlier Than
Crx/
Other class III mutations show a greater impact on retina
morphology and function than seen in Crx/ mice.13,15,20 The
original report noted that degeneration was more rapid in
L253X/X than Crx/ retinas, but suggested differences in
mouse background might be a factor.16 To directly compare
the impact of the L253X mutation with that of complete loss of
Crx, we collected retinas from 1- and 3-month WT, L253X/X,
and Crx/ mice (all backcrossed 10 generations onto C57BL/
6J) and assessed morphologic changes in H&E-stained sagittal
sections through the optic nerve head (Figs. 2D–K). At 1
month, both L253X/X and Crx/ retinas lacked photorecep-
tor outer segments (OS) and had thinner outer nuclear layers
(ONL) than the WT control (Figs. 2E, 2F versus 2D). However,
thinning was more pronounced in L253X/X than Crx/:
L253X/X retina had only four to five rows of ONL nuclei, while
Crx/ maintained 7 to 8 rows at the same age (Fig. 2E versus
2F). Quantitative morphometry measures showed that the ONL
of L253X/X was significantly thinner than that of Crx/ at
multiple positions (Fig. 2G, black versus solid gray). By 3
months, both models had similarly degenerated retinas with
only 2–3 rows of ONL cells left (Fig. 2I versus 2J; 2K). Since
both mutants showed normal ONL thickness at P7 through P10
(Supplementary Figs. S2A, S2B, and Tran et al.13), these results
suggest that ONL degeneration occurs earlier or at a faster pace
in L253X/X mice than in Crx/.
In addition to progressive ONL loss, L253X/X also
underwent age-dependent thinning of the outer plexiform
layer (OPL; Figs. 2E, 2I, Supplementary Figs. S2D, S2I, S2N, and
Won et al.16). In contrast, nonphotoreceptor cell layers (e.g.,
inner nuclear layer, ganglion cell layer) were largely unchanged
in L253X/X compared to WT controls at various ages
(Supplementary Figs. S2C–Q). These results suggest that the
L253X mutation mainly affects photoreceptor structural
integrity and survival.
L235X/X Mice Exhibit Photoreceptor Gene
Misregulation Distinct From Crx/
To further examine if the more severe morphologic phenotype
of L253X/X retinas reflected greater changes in CRX target
gene expression, we collected RNA from L253X/X and Crx/
retinas at P10 during photoreceptor terminal differentiation
prior to cell death.13 Transcripts of 14 known CRX-dependent
genes were quantified by qRT-PCR and compared both with
WT levels (Supplementary Fig. S2R) and between the two
models (Fig. 3A). Although most of these genes were
dysregulated in both mutants compared to WT mice (Supple-
mentary Fig. S2R), half of them showed statistically significant
expression differences between L253X/X and Crx/ (Fig.
3A).13,21 Three of these, Gnat1, Grk1, and especially Rho
differed markedly (>2-fold) between the two models (Fig. 3A).
Such differences in essential photoreceptor gene expression
likely contribute to the morphologic and phenotype differenc-
es between the two models.
To confirm qRT-PCR results at the protein level, we
performed immunofluorescent staining for RHO on retinal
sections of 1-month-old L253X/X, Crx/ and WT control mice.
RHO was chosen because it displayed the largest difference in
the RNA level between L253X/X and Crx/. As expected, in
WT retina, RHO was predominantly localized to the rod outer
segments (OS) with faint staining seen in ONL cell bodies (Fig.
3B). In contrast, L253X/X retina displayed no detectable RHO
immunostaining (Fig. 3C), while Crx/ retina still had weak
and spotty RHO signals localized to individual ONL cell bodies
and inner segments (Fig. 3D). These results supported the RNA
expression data and suggest that L253X mutant protein
negatively affects transcription.
Overall, the comparison between L253X/X and Crx/
indicates that L253X/X disease is more severe than that
FIGURE 3. L253X/X has measurable gene expression differences
relative to Crx/. (A) Expression at P10 of the indicated photoreceptor
genes was measured by qRT-PCR and compared between L253X/X and
Crx/ at P10. The gray dashed lines mark 2-fold differences (61 log2
relative expression) between the two genotypes (mean 6 SEM, n ‡ 3; *
P < 0.05, ** P < 0.01, **** P < 0.0001; unpaired t-test with Welch’s
Correction). (B–D) RHO immunostaining of retinal sections of the
indicated mice at 1 mo revealed less RHO expression in L253X/X
retinas than Crx/ (signal in black, scale bar: 25 lm). (E–G) DAPI
counterstaining of the above sections (signal in black).
Crx-L253X Mouse Model IOVS j September 2017 j Vol. 58 j No. 11 j 4648
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/936468/ on 11/14/2017
resulting from loss of Crx, supporting a dominant effect of the
mutation.8,13 The more severe photoreceptor deficits in
L253X/X thus presumably result from antimorphic activity of
the truncated CRX protein.
Heterozygous L253X/þMice Show Mild Decreases
in Rod and Cone Function
The L253X (TVRM65) mutation was originally reported to
cause recessive retinal disease.16 However, if the mutant
protein possesses antimorphic activity, we would hypothesize
that one copy would produce a photoreceptor phenotype. To
test this, we investigated photoreceptor function in L253X/þ
retinas by assessing electrical responses to whole retina light
stimulation. ERGs recorded at 1, 2, 3, and 5 months revealed
L253X/þ mice exhibit mild but significant reductions in ERG
amplitudes compared to WT mice (Fig. 4). At all ages tested,
dark-adapted A-waves were reduced in L253X/þ mice,
especially at high stimulus intensities (Figs. 4A–D, black line
versus gray line). Dark-adapted B-waves of L253X/þmice were
comparable to WT at 1 month (Fig. 4E), but significantly
reduced at 2, 3, and 5 months (Figs. 4F–H, black line versus
gray line). The degree of A-wave or B-wave reductions
appeared to be constant, suggesting that the defects were
unlikely a result of progressive degeneration. Reduction in
cone function was also observed: Light-adapted B-waves were
significantly decreased in L253X/þmice at 2, 3 and 5 months
(Figs. 4J–L), but not at 1 month (Fig. 4I). These results suggest
that L253X/þmice have deficits in both rod and cone function,
resembling a mild retinopathy.
L253X/þ Retinas Do Not Degenerate
To test whether the functional defects correspond to
morphologic changes, we measured retinal thickness in H&E
stained retinal sections, comparing L253X/þ and L253X/X
with WT mice at three ages (Fig. 5). Despite the progressive
retinal degeneration seen in L253X/X mice (Figs. 5C, 5D, 5G,
5H, 5K, 5L; Supplementary Figs. S2C–Q), L253X/þ showed no
degeneration or morphologic abnormalities compared to WT
controls up to 3 months of age (Figs. 5B, 5D, 5F, 5H, 5J, 5L;
Supplementary Figs. S2C–Q).
L253X/þ Retinas Display Dynamic Changes of
Photoreceptor Gene Expression
To examine developmentally regulated photoreceptor gene
expression in L253X/þ versus WT mice, we performed qRT-
PCR analyses at two early ages: P10, when rods/cones are still
terminally differentiating, and 1 month when rods/cones are
fully mature in normal retinas. The genes tested were
previously shown to dramatically change in expression during
WT rod and cone development.22 Figure 6A shows expression
changes of these genes in L253X/þ relative to WT mice at
both ages. Gene expression conformed to three general
trends in addition to the slight increase in total Crx
expression (dashed black line) noted above: Gnat1, Rho,
and Sop (solid black lines), markers of mature photorecep-
tors, were significantly decreased in L253X/þ at P10 but
attained WT levels by 1 month. Rxrg (dotted gray line), which
in WT retina loses expression over development,22 was
elevated in L253X/þ at P10 but decreased closer to WT
FIGURE 4. L253X/þ retinas exhibit reduced rod and cone light responses. ERG responses of L253X/þ mice (black lines) and WT (gray lines)
were tested at four adult ages, and dark-adapted and light-adapted A- and B-wave amplitudes quantified: (A, E, I) 1 mo; (B, F, J) 2 mo; (C, G, K) 3
mo; and (D, H, L) 5 mo (mean 6 SEM, n ‡ 3; * P < 0.05, **P < 0.01, *** P < 0.0006, **** P < 0.0001; 2-way ANOVA with Sidak’s multiple
comparisons test).
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levels by 1 month. The other genes tested, which increase
over development in WT retina, showed similar relative
expression levels at both ages that did not vary considerably
from WT (solid gray lines). Together, these gene expression
trends suggest that L253X/þ retinas exhibit altered gene
expression early in photoreceptor development, similar to
other Crx mutant models.21
To determine if L253X/þ retinas maintain photoreceptor
gene expression after differentiation, we used qRT-PCR to
examine expression of 17 essential rod and cone genes in WT
and L253X mutants at other adult ages. The results at 1, 2, 3
and 5 months (presented in a heatmap in Fig. 6B) suggest a
complex phenotype. Genes coding for transcription factors
Crx, Rxrg, Otx2, and Nrl were upregulated at many of the time
points tested. The expression of essential rod and cone
phototransduction genes showed a less clear pattern across
ages, but in general all exhibit phases of reduced expression
relative to WT.
Late PTC-Caused C-Terminal Truncation Reduces
Transactivation Function of CRX
As an initial step to understand the molecular mechanism
underlying misregulation of gene expression in L253X mutant
retinas, we asked whether a short C-terminal truncation
caused by a late PTC affects the ability of CRX to transactivate
FIGURE 5. L253X/þ retinas appear morphologically similar to WT up to 3 mo. H&E-stained retinal sections from L253X/þ, L253X/X, and WT mice
at the indicated ages: 1 mo (A–C); 2 mo (E–G); and 3 mo (I–K) were imaged at 340 magnification (scale bar: 25 lm). Images were taken
approximately 500 lm from the ONH, where differences in layer thickness are less significant. (D, H, L) ONL thickness was quantified by
morphometry at five set distances (in microns) on either side of the ONH (mean 6 SEM, n ‡ 3; * P < 0.05, ** P < 0.01, *** P < 0.001, **** P <
0.0001; 2-way ANOVA with Tukey’s multiple comparisons test).
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target gene expression. This was tested using transient
transfection assays in HEK293T cells with a Rhodopsin
(Rho) promoter-luciferase reporter (BR130-Luc).12 Vectors
expressing either the full-length (normal) or truncated CRX1-
254 were cotransfected with an NRL vector to measure their
ability to transactivate the BR130-Luc reporter. CRX1-254 did
show some dose-dependent ability to activate the Rho
promoter, suggesting that it does bind DNA and interacts
with NRL, but the maximum activity was greatly reduced
compared to the normal CRX protein (~30% of normal
activity; Fig. 7).
DISCUSSION
L253X Mouse Provides a New Class III Model for
Mild Dominant Cone-Rod Dystrophy
Although L253X (TVRM65) was originally identified as a
recessive Crx mutation,16 several pieces of evidence suggest
that L253X is antimorphic with dominant inheritance. First,
L253X retinas overexpress the mutant gene product, a
hallmark of class III mutations that amplifies the mutation’s
effects. Second, the photoreceptors in homozygous L253X/X
mice degenerate earlier than Crx/, and show patterns of
photoreceptor gene dysregulation that are distinct from Crx./
Thus, the presence of the mutant L253X protein causes more
severe pathology than absence of CRX altogether, which is
consistent with the antimorphic effect of other class III
mutations11,13,15 Furthermore, heterozygous L253X/þ mice
have early gene expression differences that largely resolve by 1
month, suggesting that full maturation may be delayed in these
retinas. Although gene expression changes in adults were
modest, rod and cone functional deficits were detectable as
early as 1 month. Previous work on class III mutants has
emphasized the effects that small changes in gene expression
over a large number of genes can have on photoreceptor
function.21 Collectively, these findings identify L253X as a class
III Crx mutation with the phenotypes summarized in the Table.
Compared to previously reported class III mutations,
pathogenicity of L253X is relatively mild. Unlike E168d2/þ
FIGURE 6. L253X/þ retinas display dynamic changes in photoreceptor gene expression. qRT-PCR analyses of L253X/þ expression levels (relative to
WT mice) of the indicated rod/cone genes are shown at P10 and 1 mo (mean 6 SEM, n ‡ 3). Lines connecting expression levels of each gene at the
two ages show the dynamic changes in expression, and reveal four different expression trends indicated here by line color and solidity, as described
in Results. (B) Heatmap depicting qRT-PCR-detected expression changes of the listed photoreceptor genes in L253X/þ relative to WT at the
indicated ages. Data are clustered based on gene expression patterns (log2 [mean fold-change], n ‡ 3). Colored gene names indicate expression in
specific photoreceptor subtype(s). TF indicates transcription factors expressed by rods and/or cones that are essential for cell fate specification.
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photoreceptors, which lose their OS and undergo progressive
degeneration,13 L253X/þ photoreceptors show normal mor-
phology and do not degenerate. The ERG deficits do not
worsen with age relative to C57BL/6J controls. The gene
expression changes are also relatively modest with a
multiphasic nature. This evolving expression pattern with
increased levels of many TFs, but modest depletion of
phototransduction cascade components, likely reflects an
inability of the cells to maintain a proper homeostasis. This
data would suggest that unknown feedback mechanisms are
operational but unable to achieve the necessary precision. In
adults, L253X/þ photoreceptors are alive and functional
through 5 months, but it remains to be determined if the
phenotype worsens at older ages or if the retina is more
susceptible to environmental insults as reported with other
class III mutants. Nevertheless, given the huge phenotypic
variability of human CRX diseases, the L253X mouse provides
a valuable animal model for understanding the pathogenesis
of class III mutations and the underlying molecular mecha-
nisms that determine phenotype severity, age of onset and
disease progression.
The Molecular Mechanism(s) Underlying L253X
Pathogenicity
The pathogenicity of class III mutations is generally determined
by two factors, the activity and dose of the mutant protein.
L253X protein contains an intact DNA binding domain but
lacks a portion of the C-terminal activation domain (Fig. 1A).
Thus, it likely retains the ability to bind DNA, but loses some
aspect of transactivation function. Transient transfection assays
showed that CRX1-254, a truncated CRX protein similar to
L253X, retained only 30% of the normal CRX activity, very
similar to the published reports.12,14 By comparison, the class
III mutant protein E168d2 showed 25% to 30% of the
transactivation activity under similar conditions.12,13 Previous
reports have also shown CRX1–254 binds appropriate DNA
sequence elements very similar to full-length CRX.14 It is
conceivable that, as previously reported for E168d2,13 L253X
protein may compete with normal CRX to bind to target genes,
interfering with normal CRX function in heterozygous mice.
However, transient transfection assays testing this hypothesis
did not show this effect on the Rho-promoter luciferase
reporter (data not shown). The antimorphic competition may
not be limited to CRX, but could also affect other homeodo-
main transcription factors that bind to similar DNA targets, and
as such transient cell transfection assays on a single reporter
that lacks the native chromatin context and regulatory
architecture may not be the proper experiment. Supporting
this possibility, the retinas of L253X/X mutants, like E168d2/
d2,13 showed more severe degeneration and biochemical
defects than Crx/ retinas. Other potential targets could
include OTX2,23 which is upregulated in L253X retinas (Fig.
6B). Additional experiments are required to demonstrate
dominant-negative activity of L253X on CRX and OTX2.
Despite the similarity between L253X and E168d2, L253X/þ
mice have a remarkably milder phenotype than E168d2/þ; it is
unlikely that the <10% difference in transactivation activity can
account entirely for the significant difference between the two
models. We therefore propose that the relative amounts of
mutant and normal CRX protein must also play a role in
phenotype severity.
L253X Allele-Specific Overproduction of Mutant
mRNA and Protein Has Implications for the PTC
Position Effect
Careful analysis of Crx mRNA and protein in L253X/þ and
L253X/X retinas clearly shows an increased ratio of mutant/
normal protein and mRNA. This finding supports the
hypothesis that, like other class III models, L253X retinas
accumulate mutant transcripts, leading to overproduction of
the CRX mutant protein. Interestingly, however, the degree of
mutant RNA accumulation in L253X/þ is lower than that of
the other class III models carrying early PTC mutations.
L253X mice only display a modest accumulation (57%
mutant/43% normal), especially when compared to that
observed in E168d2/þ mice at the same age (85% mutant/
15% normal).13 Also, when considered with the quantification
of total Crx mRNA, the L253X/þ must result in a downreg-
ulation of the normal allele as there is no aggregate
overproduction of Crx. This suggests that the L253X mRNA
is still ‘‘sensed’’ by the feedback regulatory mechanism,
which functions normally in the mutant retina. Future studies
could probe this feedback mechanism by comparing to the
E168d2/þ retinas where although there is a gross increase in
total Crx mRNA, the normal allele maintains normal
expression levels.13 Both mouse models show overproduc-
tion of mutant protein relative to WT, but L253X accumulates
at a slower rate than E168d2.
The mechanism for allele-specific overproduction of mutant
Crx in class III models is not well understood, but likely stems
from increased RNA stability due to the presence of the PTC in
TABLE. Summary of L253X Related Phenotypes
Phenotype Crx-L253X/X Crx-L253X/þ
Morphology (histology) ONL degeneration earlier than Crx/ No detectable abnormality up to 5 mo
Function (ERG) Lack of rod and cone responses to light Minor reductions in rod and cone function
Gene expression (qRT-PCR) Altered gene expression distinct from Crx/ Dynamic changes from WT
CRX protein/RNA levels L253X protein/RNA overproduction Increased ratio of L253X versus normal
FIGURE 7. L253X retains minimal ability to transactivate rhodopsin
promoter in the presence of NRL. Dual luciferase assays showing a
dose-dependent increase in CRX transactivation activity of normal or
mutant (CRX1-254) in the presence of constant amount of NRL (mean 6
SEM, n¼ 3; **** P < 0.0001; 2-way ANOVA with Bonferroni’s multiple
comparisons test).
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the last exon. This hypothesis further predicts that the position
of the PTC influences the rate of mutant RNA accumulation.
Indeed, L253X with a later PTC showed less RNA accumula-
tion than the two early PTC alleles, E168d2 and A182d1 (Fig.
1). Thus, the earlier the PTC is, the more mutant product
accumulates. These differences between early versus late PTCs
may be attributed to the length of PTC-determined 30UTR,
within which multiple discrete elements could independently
and additively contribute to mRNA hyperstability. Future
identification of novel RNA regulatory elements shared among
different PTC mutations may shed light on the mechanisms for
mutant transcript hyperstability and phenotype variability in
class III CRX disease. It is also notable that the accumulation of
mutant protein in L253X retinas is more prominent than
mutant RNA, raising the new possibility that altered protein
turnover rate could also contribute to mutant protein
accumulation.
In conclusion, our in-depth characterization of the Crx-
L253X (TVRM65) mouse supports the classification of L253X
as a dominant class III Crx mutation and provides a new animal
model for understanding CRX-associated dominant retinopa-
thies. The insights gained will hopefully lead to new treatment
strategies for this complex disease.
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